Verdon, Rhyza Mae M.
HRN: 10-46-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
CEFUROXIME 750MG (VIAL)
11/12/2025
11/19/2025
IV
750mg
Q8hours
PCAP-C
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes